← Back to Search

Local Anesthetic

Serratus Anterior Plane Block for Rib Fractures

Phase 4
Recruiting
Led By Judy Lin, MD
Research Sponsored by Antonios Likourezos
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18 years or older
Pain Score 5 or greater
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 hours
Awards & highlights

Study Summary

This trial is testing whether the serratus anterior plane block (SAPB) is better than conventional management with medications for patients with multiple rib fractures. The primary objective is to evaluate whether SAPB results in a greater improvement in percent predicted vital capacity compared to standard therapy with a sham injection.

Who is the study for?
This trial is for adults over 18 with at least two acute rib fractures on one side, causing significant pain (score of 5 or more). It's not for those with infections at the injection site, only backside rib fractures, certain drug allergies, pregnancy, need for urgent surgery, substance abuse history, low blood pressure, mental status issues preventing consent or spirometry performance.Check my eligibility
What is being tested?
The study tests if a Serratus Anterior Plane Block (SAPB), guided by ultrasound to manage pain and improve lung function in patients with multiple rib fractures is better than standard treatment. The main goal is to see if SAPB increases vital capacity more effectively than a sham procedure.See study design
What are the potential side effects?
Potential side effects may include reactions at the injection site like swelling or infection. There could also be allergic reactions to the local anesthetics used in SAPB. Side effects from acetaminophen can range from nausea to liver damage in severe cases.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 years old or older.
Select...
My pain level is 5 or higher.
Select...
I have two or more broken ribs on one side between my upper and middle back.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Vital Capacity
Secondary outcome measures
Pain Control
Other outcome measures
Opiate Usage

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: serratus anterior plane block groupActive Control2 Interventions
The injection of bupivicaine into the chest muscle is performed with an ultrasound machine which can see the needle as it enters the muscle. The skin is cleaned with a sterile solution and the needle is guided right next to the chest muscle where either the bupivicaine injected. After the injection, the needle is taken out.
Group II: Placeoo injection groupPlacebo Group2 Interventions
The injection of normal saline into the chest muscle is performed with an ultrasound machine which can see the needle as it enters the muscle. The skin is cleaned with a sterile solution and the needle is guided right next to the chest muscle where saline is injected. After the injection, the needle is taken out.

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Local anesthetic blocks, such as the Serratus Anterior Plane Block (SAPB), work by inhibiting nerve signal transmission in the targeted area, reducing pain sensation. This is achieved by injecting anesthetic agents near specific nerves, blocking sodium channels, and preventing the propagation of pain signals to the brain. This mechanism is crucial for pain patients as it provides targeted pain relief, minimizes the need for systemic opioids, and can improve respiratory function by allowing better chest expansion and cough effort, which is particularly important in patients with rib fractures.

Find a Location

Who is running the clinical trial?

Antonios LikourezosLead Sponsor
38 Previous Clinical Trials
8,411 Total Patients Enrolled
17 Trials studying Pain
1,258 Patients Enrolled for Pain
Judy Lin, MDPrincipal InvestigatorMaimonides Medical Center

Media Library

Bupivacaine (Local Anesthetic) Clinical Trial Eligibility Overview. Trial Name: NCT04530149 — Phase 4
Pain Research Study Groups: serratus anterior plane block group, Placeoo injection group
Pain Clinical Trial 2023: Bupivacaine Highlights & Side Effects. Trial Name: NCT04530149 — Phase 4
Bupivacaine (Local Anesthetic) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04530149 — Phase 4
~15 spots leftby Dec 2024